PUBLICATIONS

2025’s Top Clinical Trials: Closing a Transformative Year in Medicine 2025 was not a year of merely “positive” trials. It was a year defined by effect sizes, first-line shifts, and disease-modifying signals that are already changing real clinical decision-making. Across oncology, cardiometabolic disease, liver and rare disorders, several late-stage readouts stood out not because they met endpoints, but because they reset expectations — introducing new standards of Read more

Clinical Research Focus. 48th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of January 2026. Read more

The Most Transformative FDA Approvals of 2025: Therapies Redefining Clinical Research and Future Trial Strategy FDA approvals have always reflected scientific progress, but the 2025 roster does more than showcase innovation — it captures the rapidly changing nature of clinical trials themselves. This year’s approvals highlight how development programs are becoming more precise, more data-driven, and more tightly aligned with molecular insights that reshape traditional trial models. Across oncology, hematology, Read more

Infectious Disease CRO: Expertise, Services, and Capabilities for Clinical Trials Infectious diseases remain one of the most challenging areas in clinical development. Driven by rapidly evolving pathogens, emerging outbreaks, rising antimicrobial resistance, and the global burden of viral and bacterial infections, drug and vaccine developers increasingly rely on specialized Clinical Research Organizations (CROs) to accelerate clinical trials, ensure compliance, and deliver high-quality data. This article Read more